African Respondents asked to compare to typical month preCOVID19 N Among respondents who indicated baseline HCV screening and treatment volumes Declines in Hepatitis B Screening During Month of Highest Impact ID: 934034
Download Presentation The PPT/PDF document "African Region Impact of the COVID-19 Re..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
African Region
Impact of the COVID-19 Response on Hepatitis Elimination
Slide2African
Slide3Respondents asked to compare to typical month pre-COVID-19N = Among respondents who indicated baseline HCV screening and treatment volumes
Declines in Hepatitis B Screening During Month of Highest Impact
N=17
Declines in Hepatitis B Treatment During Month of Highest Impact
N=17
African
Slide4Respondents asked to compare to typical month pre-COVID-19N = Among respondents who indicated baseline HCV screening and treatment volumes
African
Declines in Hepatitis C Screening During Month of Highest Impact
N=21
Declines in Hepatitis C Treatment During Month of Highest Impact
N=15
Slide5N = Among respondents who indicated baseline OST volumes
African
Percent Disruptions in Opioid Substitution Therapy
N=2
Slide6Changes in Hepatitis Clinical Services to Decrease COVID-19 Exposures
Deferred laboratory testing (Y) - 9 (41%)
Deferred imaging (Y) - 10 (50%)
Increase pill count per prescription (Y) - 24 (95%)
African
Among respondents who provide these services
Higher than global
Lower than global
Lower than global
Slide7African
Slide8African
Slide9African
Slide10African
Slide11African
Slide12Additional Details from Open Responses
Use of General Practitioners to provide care and scripts – Physician, South Africa
We have concentrated on maintaining clinic visits for patients with viral hepatitis already in the clinic system, despite reducing overall clinic numbers by 30%. All patients who did not attend clinic visits for fear of COVID-19 were phoned to ensure that anti-viral therapy was not interrupted. – Physician
South Africa
We put in place peer to peer group to deliver drugs on foot to house holds ,delivery by bicycle and motorcycle. – Civil Society Staff, Uganda
African